Cocrystal Pharma Expands Collaboration with the National Institute of Allergy and Infectious Diseases to Evaluate COVID-19 Protease Inhibitors

Media Type
Article
Publish or Event Date
Research Institution
Cocrystal Pharma
Short Title
Cocrystal Pharma Expands Collaboration with the National Institute of Allergy and Infectious Diseases to Evaluate COVID-19 Protease Inhibitors
Content Coordinator
Content Manager